CCL2 and infection: Since macrophages represent potential viral reservoirs capable of producing replication-competent HIV-1 virions even in the presence of effective combination antiretroviral therapy, targeting CCL2 may represent a novel therapeutic strategy for enhancing cellular defences against HIV-1 and protecting macrophages from infection.